Novartis is shifting its R&D focus to India, moving operations outside of Switzerland.
1 report, 1 independent
Updated Sep 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Novartis is shifting its R&D focus to India, moving operations outside of Switzerland.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Novartis
Swiss-American multinational pharmaceutical corporation
Related events
- Novartis is headquartered in Basel, Switzerland.
- Novartis sought Swissmedic regulatory approval for a drug, which was co-funded by Sida and introduced first in Ghana.
- Novartis AG is subject to US federal securities laws.
- Major pharmaceutical companies, including Novartis, Roche, AstraZeneca, and Pfizer, maintain significant presences in Switzerland.
- Novartis is offering potential support to the national health fund in Ghana, which provides equipment and support to the Komfo Anokye Teaching Hospital.